Encompass Health Co. (NYSE:EHC) Shares Sold by Asset Management One Co. Ltd.

Asset Management One Co. Ltd. cut its stake in shares of Encompass Health Co. (NYSE:EHC) by 27.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,745 shares of the company’s stock after selling 4,489 shares during the quarter. Asset Management One Co. Ltd.’s holdings in Encompass Health were worth $1,099,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in EHC. Point72 Asset Management L.P. grew its stake in Encompass Health by 2,458.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after acquiring an additional 835,135 shares during the last quarter. Jennison Associates LLC acquired a new stake in Encompass Health in the 4th quarter valued at about $52,094,000. abrdn plc acquired a new stake in Encompass Health in the 4th quarter valued at about $17,846,000. Thrivent Financial for Lutherans grew its stake in Encompass Health by 26.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 760,496 shares of the company’s stock valued at $73,494,000 after acquiring an additional 156,938 shares during the last quarter. Finally, Franklin Resources Inc. grew its stake in Encompass Health by 22.0% in the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after acquiring an additional 126,000 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 2.10% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Barclays increased their price objective on shares of Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, February 7th. KeyCorp increased their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Truist Financial reaffirmed a “buy” rating and set a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Encompass Health has an average rating of “Buy” and an average target price of $107.67.

Encompass Health Trading Down 1.7 %

Shares of EHC stock opened at $99.87 on Friday. The firm has a market cap of $10.06 billion, a P/E ratio of 22.39, a PEG ratio of 2.36 and a beta of 0.90. Encompass Health Co. has a 1-year low of $73.68 and a 1-year high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The firm’s 50-day simple moving average is $96.00 and its 200-day simple moving average is $95.76.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. As a group, equities analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 17th. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.68%. Encompass Health’s payout ratio is currently 15.25%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.